newsfilter
← Latest News
PR Newswire·

PDL BioPharma Announces Offer to Purchase Convertible Notes Due 2021 and 2024

PDL BioPharma, Inc. ("PDL" or the "Company") (Nasdaq: PDLI) today announced that holders of its 2.75% Convertible Senior Notes due in December 2021...